In particular, CK2 inhibitors induce CLL apoptosis by reducing the activity of Protein Kinase C (PKCβ) and PKCδ, two downstream factors of PI3K, and preventing PTEN phosphorylation, thus stabilizing PTEN. This evidence concerns the gene PTEN and B-cell chronic lymphocytic leukemia.